Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
6.16 (1y: +62%)
Market Cap 53.1 M P/E(ttm) 92.00
Enterprise Value 41.89 M P/B 2.50
IRIX- NAS (USA)
Iridex Corporation
  • Currently 1/5
Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$6.16
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry		 vs
history
Cash to Debt No Debt
IRIX's Cash to Debt is ranked higher than
78% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 5.24 vs. IRIX: No Debt )
IRIX' s 10-Year Cash to Debt Range
Min: 0.59   Max: No Debt
Current: No Debt
Equity to Asset 0.72
IRIX's Equity to Asset is ranked higher than
73% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 0.53 vs. IRIX: 0.72 )
IRIX' s 10-Year Equity to Asset Range
Min: 0.21   Max: 0.88
Current: 0.72
0.21
0.88
F-Score: 4
Z-Score: 6.87
M-Score: -2.37
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry		 vs
history
Operating margin (%) -2.50
IRIX's Operating margin (%) is ranked lower than
73% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 6.00 vs. IRIX: -2.50 )
IRIX' s 10-Year Operating margin (%) Range
Min: -43.4   Max: 8.3
Current: -2.5
-43.4
8.3
Net-margin (%) 4.2
IRIX's Net-margin (%) is ranked higher than
51% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 3.90 vs. IRIX: 4.2 )
IRIX' s 10-Year Net-margin (%) Range
Min: -40.1   Max: 7.9
Current: 4.2
-40.1
7.9
ROE (%) 6.6
IRIX's ROE (%) is ranked higher than
59% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 5.10 vs. IRIX: 6.6 )
IRIX' s 10-Year ROE (%) Range
Min: -118.4   Max: 17.2
Current: 6.6
-118.4
17.2
ROA (%) 5
IRIX's ROA (%) is ranked higher than
61% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. IRIX: 5 )
IRIX' s 10-Year ROA (%) Range
Min: -47.7   Max: 10.4
Current: 5
-47.7
10.4
ROC (Joel Greenblatt) (%) -9.30
IRIX's ROC (Joel Greenblatt) (%) is ranked lower than
79% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 12.10 vs. IRIX: -9.30 )
IRIX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -180.6   Max: 32.8
Current: -9.3
-180.6
32.8
Revenue Growth (%) -3.4
IRIX's Revenue Growth (%) is ranked lower than
83% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. IRIX: -3.4 )
IRIX' s 10-Year Revenue Growth (%) Range
Min: -12.4   Max: 10.1
Current: -3.4
-12.4
10.1
EPS Growth (%) -11.4
IRIX's EPS Growth (%) is ranked lower than
83% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. IRIX: -11.4 )
IRIX' s 10-Year EPS Growth (%) Range
Min: -46.3   Max: 158.8
Current: -11.4
-46.3
158.8
ยป IRIX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

IRIX Guru Trades in Q2 2012

Jim Simons 99,300 sh (-0.9%)
» More
Q3 2012

IRIX Guru Trades in Q3 2012

Jim Simons 99,900 sh (+0.6%)
» More
Q4 2012

IRIX Guru Trades in Q4 2012

Jim Simons 98,200 sh (-1.7%)
» More
Q1 2013

IRIX Guru Trades in Q1 2013

Jim Simons 100,700 sh (+2.55%)
» More
» Details

Insider Trades

Latest Guru Trades with IRIX



No Insider Trades Found!

Ratios

vs
industry		 vs
history
P/E(ttm) 92.00
IRIX's P/E(ttm) is ranked lower than
93% of the 148 Companies
in the Global Medical Devices industry.

( Industry Median: 24.00 vs. IRIX: 92.00 )
IRIX' s 10-Year P/E(ttm) Range
Min: 9.78   Max: 199
Current: 92
9.78
199
P/B 2.50
IRIX's P/B is ranked lower than
58% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. IRIX: 2.50 )
IRIX' s 10-Year P/B Range
Min: 0.41   Max: 4.22
Current: 2.5
0.41
4.22
P/S 1.63
IRIX's P/S is ranked higher than
56% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 2.02 vs. IRIX: 1.63 )
IRIX' s 10-Year P/S Range
Min: 0.1   Max: 3.75
Current: 1.63
0.1
3.75
EV-to-EBIT 166.7
IRIX's EV-to-EBIT is ranked lower than
96% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 19.44 vs. IRIX: 166.7 )
IRIX' s 10-Year EV-to-EBIT Range
Min: 7.9   Max: 1115.6
Current: 166.7
7.9
1115.6
Shiller P/E 323.3
IRIX's Shiller P/E is ranked lower than
100% of the Companies
in the Global Medical Devices industry.

( Industry Median: vs. IRIX: 323.3 )
IRIX' s 10-Year Shiller P/E Range
Min: 34.27   Max: 1080
Current: 323.3
34.27
1080

Valuation & Return

vs
industry		 vs
history
Price/Net Cash 10.8
IRIX's Price/Net Cash is ranked higher than
51% of the 69 Companies
in the Global Medical Devices industry.

( Industry Median: 10.90 vs. IRIX: 10.8 )
IRIX' s 10-Year Price/Net Cash Range
Min: 2.7   Max: 37.4
Current: 10.8
2.7
37.4
Price/Net Current Asset Value 6.1
IRIX's Price/Net Current Asset Value is ranked higher than
71% of the 190 Companies
in the Global Medical Devices industry.

( Industry Median: 13.30 vs. IRIX: 6.1 )
IRIX' s 10-Year Price/Net Current Asset Value Range
Min: 0.7   Max: 6.2
Current: 6.1
0.7
6.2
Price/Tangible Book 2.5
IRIX's Price/Tangible Book is ranked higher than
58% of the 191 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. IRIX: 2.5 )
IRIX' s 10-Year Price/Tangible Book Range
Min: 0.7   Max: 2.3
Current: 2.5
0.7
2.3
Price/DCF (Projected) 1.9
IRIX's Price/DCF (Projected) is ranked lower than
66% of the 73 Companies
in the Global Medical Devices industry.

( Industry Median: 1.50 vs. IRIX: 1.9 )
IRIX' s 10-Year Price/DCF (Projected) Range
Min: 0.5   Max: 2.2
Current: 1.9
0.5
2.2
Price/Median PS Value 1.7
IRIX's Price/Median PS Value is ranked lower than
86% of the 195 Companies
in the Global Medical Devices industry.

( Industry Median: 1.00 vs. IRIX: 1.7 )
IRIX' s 10-Year Price/Median PS Value Range
Min: 0.2   Max: 1.9
Current: 1.7
0.2
1.9
Price/Graham Number 2.1
IRIX's Price/Graham Number is ranked lower than
59% of the 143 Companies
in the Global Medical Devices industry.

( Industry Median: 1.90 vs. IRIX: 2.1 )
IRIX' s 10-Year Price/Graham Number Range
Min: 0.9   Max: 2.4
Current: 2.1
0.9
2.4
Earnings Yield (Greenblatt) 0.60
IRIX's Earnings Yield (Greenblatt) is ranked lower than
75% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. IRIX: 0.60 )
IRIX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 12.7
Current: 0.6
0.1
12.7
Forward Rate of Return (Yacktman) 1.71
IRIX's Forward Rate of Return (Yacktman) is ranked higher than
75% of the 214 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. IRIX: 1.71 )
IRIX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -3.8   Max: 3.6
Current: 1.71
-3.8
3.6

Business Description

Iridex Corporation was incorporated in California in February 1989 as IRIS Medical Instruments, Inc. In November 1995, the Company changed its name to IRIDEX Corporation and reincorporated in Delaware. It is a worldwide provider of therapeutic based laser systems and delivery devices used to treat eye diseases in ophthalmology and skin conditions in dermatology. IRIDEX's ophthalmology products are used in the treatment of serious eye diseases, including the three causes of irreversible blindness, age-related macular degeneration, diabetic retinopathy and glaucoma. In addition, its ophthalmology products are often used in vitrectomy procedures which are generally performed in the operating room and require a disposable single use laser probe to deliver the light to the back of the eye. The current family of OcuLight laser systems, which accounts for the majority of its revenues, is used for ophthalmic applications mainly in operating rooms, clinics and doctors' offices includes the IRIS Medical IQ810 Laser System, OcuLight TX, the OcuLight Symphony, OcuLight SL, OcuLight SLx, OcuLight GL and OcuLight GLx laser photocoagulation systems. The company's dermatology products treat skin conditions, mainly vascular and pigmented lesions and remove unwanted hair. In January 2007, the company acquired Laserscope's aesthetics business (the Laserscope acquisition) including its subsidiaries in France and the United Kingdom (UK) from American Medical Systems Holdings (AMS). The aesthetics products acquired through the Laserscope acquisition include the Gemini, Venus-i, Lyra-i and Aura-i Laser Systems, as well as the following delivery devices: the VersaStat 10 mm, VersaStat-i, and Dermastat handpieces along with an articulated arm for the Venus-i Laser System. These products focus on the treatment of pigmented and vascular lesions, skin rejuvenation, skin tightening, hair reduction, leg veins, and acne. The company's previous dermatology lasers, called the DioLite XP and the VariLite Dual Wavelength Laser Systems, were folded in with the Laserscope aesthetics product offering to create an expanded aesthetics business. Its products are sold in the United States predominantly through a direct sales force and internationally through 100 independent distributors in more than 100 countries.
Company Website
SEC Reports
Industry: Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ
ยป More Articles for IRIX

Headlines

Articles On GuruFocus.com
IRIDEX Corp. Reports Operating Results (10-Q) Nov 04 2010 
IRIDEX Corp. Reports Operating Results (10-Q) Aug 05 2010 
IRIDEX Corp. Reports Operating Results (10-Q) May 06 2010 
IRIDEX Corp. Reports Operating Results (10-Q) Nov 12 2009 
IRIDEX Corp. Reports Operating Results (10-Q) Aug 13 2009 
IRIDEX Corp. Reports Operating Results (10-Q) May 15 2009 
IRIDEX Corp. (IRIX) CFO James H Mackaness buys 2,000 Shares Mar 13 2009 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial